FLT3 and acute myeloid leukemia: Mutations in the D835 position of FLT3 represent the most frequent point mutations in FLT3 (7–10% of patients with AML), with aspartic acid (D) to tyrosine (Y) being by far the most common amino acid substitution, although other substitutions can also occur32.